The global COVID traditional Chinese medicine treatment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Traditional Chinese medicine (TCM) has been shown to be useful in the treatment of severe acute respiratory syndrome (SARS) that occurred in 2003. (SARS). Many Chinese patients with COVID-19, according to official Chinese press reports, benefit from TCM. The distinction of syndromes is an important feature of Chinese medicine. According to TCM theory, COVID-19 has four stages: early-stage, medium stage, severe stage, and recovery stage.
Most patients suffer symptoms such as fever, cough, sore throat, and chills in the early stages of COVID-19, said Dr. Liwei Yin, first author of the study and a physician at Guangzhou University of Chinese Medicine’s First Affiliated Hospital. “This is the lungs’ manifestation of heat, cold, or wetness.” The top three Chinese herbs used in this stage are Kuxingren (Semen Armeniacae Amarum), Baidoukou (Amomum kravanh), and Houpo (Magnolia Officinalis Cortex).
Most patients have TCM symptoms of plague toxin blocking the lungs when in the middle stage. The most commonly utilized Chinese herbs in this period include Kuxingren (Semen Armeniacae Amarum), Shigao (Gypsum Fibrosum), and Tinglizi (Descurainiae Semen). Dyspnea and coma were the most common presenting symptoms in the severe stage. Often, a mechanical ventilator and ECMO are required. The top three Chinese herbs used in this period are Renshen (Ginseng Radix et Rhizoma), Fuzi (Aconiti Lateralis Radix Praeparata), and Shanyurou (Fructus Corni). “Fuzi reduces heart failure, but it also has neurotoxicity and cardiac toxicity,” said Dr Ziping Li, a professor at Guangdong Provincial Hospital of Traditional Chinese Medicine and the study’s primary author for communication. “When Gancao and Ganjiang are used simultaneously, the efficacy and toxicity of Fuzi can be controlled.”
Patients with TCM syndromes of Lung-spleen qi insufficiency and Qi-yin deficiency frequently experience TCM syndromes of Lung-spleen qi deficiency and Qi-yin deficiency throughout the healing period. The most commonly utilized Chinese herbs in this stage are Fuling (Poria), Fabanxia (Pinelliae Rhizoma), and Chenpi (Citri Reticulatae Pericarpium). “Combining Chinese herbs can improve their efficiency while reducing negative effects,” Liwei Yin explained. “High-frequency herb pairs and possible herbal combinations were also discovered as a result of this research.”
Some major players in the market include Beijing Juxiechang Pharmaceutical Co Ltd, Beijing Yiling Pharmaceutical Co Ltd, Shijiazhuang Yiling Pharmaceutical Co Ltd, Shijiazhuang Yiling Pharmaceutical Co Ltd, Tianjin Chase Sun Pharmaceutical Co Ltd, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.
(Get 15% Discount on Buying this Report)
Get Sample Copy of COVID Traditional Chinese Medicine Treatment Market at: https://orionmarketreports.com/request-sample/?id=96954&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Beijing Juxiechang Pharmaceutical Co Ltd, Beijing Yiling Pharmaceutical Co Ltd, Shijiazhuang Yiling Pharmaceutical Co Ltd,, Shijiazhuang Yiling Pharmaceutical Co Ltd, Tianjin Chase Sun Pharmaceutical Co Ltd, among others.
A full report COVID Traditional Chinese Medicine Treatment Market of is available at: https://orionmarketreports.com/covid-traditional-chinese-medicine-treatment-market/96954/
Global COVID Traditional Chinese Medicine Treatment Market Report by Segment
By Type
- Lianhua Qingwen Capsule
- Xuebijing Injection
- Jinhua Qinggan Granule
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
